Opendata, web and dolomites

Reminova02

Feasibility Study to Demonstrate Effectiveness and Efficiency of Enamel Remineralisation using Reminova's EAER (Electrically Accelerated Enhanced Remineralisation) Technology for Dental Applications

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Reminova02 project word cloud

Explore the words cloud of the Reminova02 project. It provides you a very rough idea of what is the project "Reminova02" about.

customer    validate    teeth    reparative    adult    timeframes    tiny    consumers    minute    60bn    population    building    claims    meet    entry    public    dentistry    electrically    lifetime    techniques    effectiveness    anticipated    formulations    precavitated    opposed    world    electric    remineralisation    methodology    filling    initial    planning    maintains    market    tissue    feasibility    health    global    regrows    device    globally    dentists    economy    optimisation    critical    disease    solution    crisis    repairs    36    drilling    accelerated    organisation    award    patients    suitable    decay    embrace    anaesthesia    viability    removal    treatment    15    subsequent    optimise    frame    4bn    lesions    office    reminova    preventative    rapid    core    eaer    enhanced    caries    keen    treat    curative    2008    replacing    first    communicable    time    unperceivable    enamel    scalability    welcomed    dental    painless    tooth    commercial    retain    believe    shift    pull   

Project "Reminova02" data sheet

The following table provides information about the project.

Coordinator
REMINOVA LTD 

Organization address
address: DENTAL INNOVATION AND TRANSLATION CENTRE INVERALMOND BUSINESS CENTRE 6 AULD BOND ROAD
city: PERTH
postcode: PH1 3FX
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.reminova.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-05-01   to  2016-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REMINOVA LTD UK (PERTH) coordinator 50˙000.00

Map

 Project objective

'Dental caries (tooth decay) is the most common communicable disease, globally affecting 36% of the adult population. It has been identified by the World Health Organisation (WHO) as a major global public health crisis (2008) and costs the European economy an estimated at €60Bn. Reminova is developing technology that 'regrows' enamel, replacing the need for dental anaesthesia and drilling in the treatment of caries. The novel approach requires the delivery of three formulations to the tooth using a tiny (unperceivable) electric current in a process known as Electrically Accelerated Enhanced Remineralisation (EAER). This will be used to treat caries in-office without the need for tooth tissue removal. Our development has been welcomed by both end consumers and the dentistry sector and there is a strong market pull to get our technology to market. Patients want a painless solution that maintains and repairs their teeth, so they may retain them throughout their lifetime. Dentists are keen to embrace a shift to preventative and curative dentistry as opposed to the current reparative approach used when drilling and filling teeth. To achieve market success it is anticipated the device should control rapid remineralisation of precavitated lesions within existing timeframes and treatment pathways. This Phase 1 H2020 award would be used to undertake initial feasibility work and planning on how we can optimise remineralisation to a 15 minute time-frame. We believe that this is critical to the commercial viability and scalability of an identified €1.7–4.4Bn global market in the first 3 years of market entry for the device. The core activities of our phase 1 project would be initial feasibility work on techniques for optimisation and building a suitable approach and methodology for a subsequent phase 2 application. This will be essential to demonstrate the effectiveness of the technology to meet customer needs and validate market claims, thus achieving commercial success. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REMINOVA02" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REMINOVA02" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

ATRS Instrument (2015)

Real time analysis of tablet and capsule dosage during pharmaceutical manufacturing

Read More  

WORKSHOP4.0 (2016)

Automated real-time production forecasting for industry

Read More